July 26, 2024
FDA Warns Consumers Not to Use OPMS Black Liquid Kratom

FDA Warns Consumers Not to Use OPMS Black Liquid Kratom

Important Notice to Consumers

Audience

Consumers who have recently purchased OPMS Black Liquid Kratom.

Product

OPMS Black Liquid Kratom sold online and in certain retail stores.

Purpose

The FDA is advising consumers not to consume OPMS Black Liquid Kratom, which is linked to serious adverse health effects, including death.

Summary of Problem and Scope

The FDA recently received an adverse event report of a person who died after using OPMS Black Liquid Kratom. This is one of many reports of serious adverse events related to this product. Other reported health effects include:

  • Withdrawal symptoms
  • Addiction
  • Digestive issues
  • Restless leg syndrome
  • Skin problems
  • Aggressive behavior
  • Increased anxiety
  • Lack of energy
  • Inability to focus

The product label indicates the presence of kratom alkaloids: mitragynine and 7-hydroxymitragynine (7-OH mitragynine).

FDA’s Stance on Kratom Products

Products containing kratom have been marketed as foods, dietary supplements, or drugs with therapeutic claims. However, the FDA has not approved any prescription or over-the-counter drug products containing kratom or its compounds, mitragynine and 7-OH mitragynine.

The FDA has concluded that kratom is not lawfully marketed as a dietary supplement and cannot be added to conventional foods due to serious safety concerns. These concerns include risks of liver toxicity, seizures, and substance use disorder (SUD).

FDA Actions and Response

The FDA continues to evaluate adverse event reports for all kratom-containing products. This safety alert aims to warn consumers about the serious health effects associated with OPMS Black Liquid Kratom.

Recommendations for Consumers

Consumers should:

  • Not consume OPMS Black Liquid Kratom.
  • Report any adverse medical events to the FDA.

How to Report to the FDA

  • Call an FDA Consumer Complaint Coordinator to speak directly about your problem.
  • Complete an electronic Voluntary MedWatch form online.
  • Complete a paper Voluntary MedWatch form and mail it to the FDA.

For additional assistance, visit the FDA Consumer Complaint System.


Need Help Navigating These Updates?

Garg Law is here to assist you with understanding and complying with these FDA updates. Our expertise in FDA regulations ensures you stay compliant and informed.

Contact Us today for tailored legal advice and support.

Read the full FDA article here.

Contact us
Thank you for your interest in Garg Law PLLC.
Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.
If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.
Garg Law Global Icon

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.